文献速递冠心病外科

症状性心肌桥的长期结局与治疗策略

Symptomatic myocardial bridge: Long-term outcomes and strategies.
PubMed 文献 · J Thorac Cardiovasc Surg · 2025-08-14

该回顾性研究纳入243例冠脉造影诊断的心肌桥患者,比较手术与药物治疗的长期结局。中位随访55.6-85.3个月,手术组10年无主要不良心脏事件率高于药物组。孤立性心肌桥且收缩压迫≥70%者,手术优于药物。

要点

  • 孤立性心肌桥收缩压迫≥70%且药物难治者,心肌切开术结局优于药物。
  • 心肌桥合并其他心脏手术时,同期心肌切开术可获得满意结局。
  • 症状性孤立性心肌桥收缩压迫<70%者,药物治疗可获得良好结局。

核心结论

  • 孤立性心肌桥收缩压迫≥70%且药物难治者,心肌切开术结局优于药物治疗。
  • 心肌桥合并其他心脏疾病时,同期心肌切开术可获满意结局。
  • 症状性孤立性心肌桥收缩压迫<70%者,药物治疗可获良好结局。

研究设计与样本

  • 回顾性研究纳入243例冠脉造影诊断的心肌桥患者。
  • 手术组77例:A1组31例压迫≥70%,A2组46例合并其他心脏手术。
  • 药物组166例:B1组125例压迫<70%,B2组41例压迫≥70%。

主要发现

  • A组平均随访55.6个月,B组平均随访85.3个月。
  • A1、A2、B1、B2组10年累积生存率分别为95%、92.1%、93.4%、88.2%。
  • A1、A2、B1、B2组10年无主要不良心脏事件率分别为89.7%、85.0%、74.4%、67.8%。
  • 孤立性心肌桥收缩压迫≥70%者,B2组主要不良心脏事件发生率显著高于A1组(P=.01)。
  • 所有组治疗后西雅图心绞痛问卷评分均显著改善(P<.01)。

临床怎么用

  • 孤立性心肌桥收缩压迫≥70%且药物难治者,可考虑心肌切开术。
  • 心肌桥合并其他心脏手术时,可同期行心肌切开术。
  • 症状性孤立性心肌桥收缩压迫<70%者,可首选药物治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To analyze clinical outcomes and prognosis under different treatment strategies for myocardial bridging (MB) patients, providing evidence to optimize clinical decision-making. METHODS: A retrospective study was conducted on 243 patients diagnosed with MB by coronary angiography at our institution. Of them, 77 patients underwent surgery (group A), and were divided into group A1 (n = 31, compression ≥70%) and group A2 (n = 46, combined with other heart surgeries). The remaining 166 patients underwent medical treatment and were divided into group B1 (n = 125, compression <70%) and group B2 (n = 41, compression ≥70%). The quality of life, mortality, and major adverse cardiac events were analyzed for each group. RESULTS: Mean follow-up was 55.6 months in Group A and 85.3 months in Group B. The10-year cumulative survival rates for group A1, A2, B1, B2 were 95%, 92.1%, 93.4%, and 88.2%, and the 10-year rates of freedom from major adverse cardiac events in these groups were 89.7%, 85.0%, 74.4%, and 67.8%, respectively. For patients with isolated MB and systolic compression ≥70%, the incidence of major adverse cardiac events was significantly higher than in group B2, compared with group A1 (P = .01). Seattle Angina Questionnaire (SAQ) scores improved significantly after treatment across all groups (P < .01). CONCLUSIONS: For patients with isolated MB and systolic coronary compression ≥70%, and refractory to medical therapy, myotomy had better outcomes than medical therapy. In cases with MB coexisting with other cardiac diseases, myotomy with other cardiac surgeries can achieve satisfactory outcomes. For symptomatic patients with isolated MB and systolic coronary compression <70%, medical treatment can yield good outcomes.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Zhang M, Wu Q, Zhang Z, et al. Symptomatic myocardial bridge: Long-term outcomes and strategies. J Thorac Cardiovasc Surg. 2025. PMID: 40818786. doi:10.1016/j.jtcvs.2025.08.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。